Back to search results

Study on Skin Cancer Prevention Messages

This study is looking at how different types of information about skin cancer risk can encourage people to take steps to prevent it. Researchers want to see if a "Precision Prevention Booklet," which includes information about your specific genetic risk (MC1R risk), is more effective than a "Standard Prevention Booklet" that doesn't mention this genetic risk. You might be able to join if you are 18 or older, a patient at one of the six Tampa Family Health Centers, and have reported intentional sun exposure or sunburns in the past year. The study will measure changes in tanning habits, number of sunburns, and how often you check your skin over 12 months to see which booklet works best. The current recruitment status is unclear.

Study design
This study is an interventional trial planning to enroll 2900 participants. It compares two different behavioral interventions: a Precision Prevention Booklet and a Standard Prevention Booklet.
What's involved
The study measures changes in tanning score, number of sunburns, and skin self-examination at the start, 6 months, and 12 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 12 months after the start of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07222995

Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs

Recruiting
NAAges 18+InterventionalPrevention
H. Lee Moffitt Cancer Center and Research Institute
~2,900 participants
Updated 2026-02-05 on ClinicalTrials.gov
What's tested:Precision Prevention BookletStandard Prevention Booklet

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Tanning Score
Measured over Baseline, 6 months, 12 months
+3 more outcomes measured

Conditions

Skin Cancer

Explore related trials

Malignant Skin NeoplasmMC1R Gene

Where it's being run

2 sites across 2 states
Florida1
New York1

Study leadership

  • Peter Kanetsky, PhD, MPH · PRINCIPAL_INVESTIGATOR · Moffitt Cancer Center

Who to contact

Rania Abdulla
[email protected]
813-745-6813
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Be a patient of any race or ethnicity attending one of the six Tampa Family Health Centers.
Be 18 years of age or older.
Self-report skin cancer risk behaviors within the past 12 months, including: Intentional sun exposure (e.g., outdoor or indoor tanning) or unintentional sun exposure leading to sunburn.
Be willing to complete a baseline questionnaire and provide a saliva sample for MC1R genotyping.
Be able to provide informed consent (written or electronic).
Prefer English or Spanish for communication and study materials.

Exclusion

Do not report any skin cancer risk behaviors (i.e., no tanning or sunburning in the past 12 months).
Are unwilling or unable to complete the baseline assessment or return the saliva kit.
Decline to provide informed consent.
Are under 18 years of age.

What this trial measures

  • Change in Tanning ScoreBaseline, 6 months, 12 months

    Change in self-reported tanning behavior score from baseline to 6 and 12 months.

  • Number of SunburnsBaseline, 6 months, 12 months

    Change in self-reported number of sunburns experienced over the past 6 and 12 months.

  • Skin self-examination (SSE)Baseline, 6 months, 12 months

    Change in self-reported SSE from baseline to 6 and 12 months.

  • Physician-patient communication about skin cancer prevention.Baseline, 6 months, 12 months

    Change in self-reported physician-patient communication from baseline to 6 and 12 months.